1)厚生労働科学研究費補助金 難治性疾患政策研究事業 プリオン病及び遅発性ウイルス感染症に関する調査研究班: 進行性多巣性白質脳症(progressive multifocal leukoencephalopathy: PML)診療ガイドライン 2023. http://prion.umin.jp/guideline/pdf/guideline_PML_2013.pdf(最終閲覧日: 2024年9月1日)
2)Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, et al: MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry 87: 1138-1145, 2016
3)Arai Y, Tsutsui Y, Nagashima K, Shinmura Y, Kosugi T, et al: Autopsy case of the cerebellar form of progressive multifocal leukoencephalopathy without immunodeficiency. Neuropathology 22: 48-56, 2002
4)Adra N, Goodheart AE, Rapalino O, Caruso P, Mukerji SS, et al: MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation. AJNR Am J Neuroradiol 42: 1073-1079, 2021
5)Nakamichi K, Kawamoto M, Ishii J, Saijo M: Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy. BMC Neurol 19: 252, 2019[doi: 10.1186/s12883-019-1476-2]
lymphocytopenia. Neuropathology 41: 484-488, 2021
7)Nakamichi K, Miura Y, Shimokawa T, Takahashi K, Suzuki T, et al: Nationwide laboratory surveillance of progressive multifocal leukoencephalopathy in Japan: fiscal years 2011-2020. Viruses 15: 968, 2023
8)Sakurai S, Maezawa M, Nakao S, Hirofuji S, Miyasaka K, et al: Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report database. J Neurol Sci 455: 122789, 2023
9)Rindi LV, Zaçe D, Braccialarghe N, Massa B, Barchi V, et al: Drug-induced progressive multifocal leukoencephalopathy (PML): a systematic review and meta-analysis. Drug Saf 47: 333-354, 2024